NEW YORK, Jan. 29, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the closing of its previously announced underwritten public offering of 2,898,550 shares of its common stock. The shares were sold at the public offering price of $15.00 per share, bringing the aggregate gross proceeds from the offering to approximately $43.5 million, before deducting underwriting discounts and commissions and other offering expenses.
Help employers find you! Check out all the jobs and post your resume.
